AnalyzeDirect Babovic-Vuksanovic D, Ballman K, Michels V, McGrann P, Lindor N, King B, Camp J, Micic V, Babovic N, Carrero X, Spinner R, O’Neill B. Phase II trial of pirfenidone in adults with neurofibromatosis type 1. Neurology. November 2006;67(10):1860-1862.
Publication Date
November 2006
How Analyze was Used
“Tumor volumes were determined by standard perimeter tracing and segmentation with automated voxel summation technique using Analyze, a comprehensive image visualization and analysis software package.”
Keywords
Adolescent
Adult
Aged
Antineoplastic Agents/administration & dosage/adverse effects
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Magnetic Resonance Imaging (MRI)
Male
Middle Aged
Neuralgia/drug therapy/etiology/physiopathology
Neurofibroma/drug therapy/pathology/physiopathology
Neurofibromatosis 1/drug therapy/pathology/physiopathology
Peripheral Nerves/drug effects/pathology/physiopathology
Peripheral Nervous System Neoplasms/drug therapy/pathology/physiopathology
Pyridones/administration & dosage/adverse effects
Treatment Outcome
Author Affiliation(s)
Department of Medical Genetics, Mayo College of Medicine, Rochester, MN, US. (DB-V, VM, PM, NL)
Department of Radiology, Mayo College of Medicine, Rochester, MN, US. (BK)
Department of Neurology, Mayo College of Medicine, Rochester, MN, US. (BO)
Department of Neurosurgery, Mayo College of Medicine, Rochester, MN, US. (RS)
Biomedical Imaging Resource, Mayo College of Medicine, Rochester, MN, US. (JC, VM, NB)
Health Sciences Research, Mayo College of Medicine, Rochester, MN, US. (XC)
ID# 1840
Tags: Adolescent, Adult, Aged, Antineoplastic Agents/administration & dosage/adverse effects, Drug Administration Schedule, Drug Dose-Response Relationship, Female, Humans, Magnetic Resonance Imaging (MRI), Male, Middle Aged, Neuralgia/drug therapy/etiology/physiopathology, Neurofibroma/drug therapy/pathology/physiopathology, Neurofibromatosis 1/drug therapy/pathology/physiopathology, Peripheral Nerves/drug effects/pathology/physiopathology, Peripheral Nervous System Neoplasms/drug therapy/pathology/physiopathology, Pyridones/administration & dosage/adverse effects, Treatment Outcome